These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 24870133)

  • 1. Using bioinformatics tools to study the role of microRNA in cancer.
    Passetti F; Jorge NA; Durham A
    Methods Mol Biol; 2014; 1168():99-116. PubMed ID: 24870133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of bioinformatics prediction in microRNA-based cancer therapeutics.
    Banwait JK; Bastola DR
    Adv Drug Deliv Rev; 2015 Jan; 81():94-103. PubMed ID: 25450261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and cancer-the search begins!
    Oulas A; Reczko M; Poirazi P
    IEEE Trans Inf Technol Biomed; 2009 Jan; 13(1):67-77. PubMed ID: 19129025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA expression profiling in cancer from a bioinformatics prospective.
    Gusev Y; Brackett DJ
    Expert Rev Mol Diagn; 2007 Nov; 7(6):787-92. PubMed ID: 18020908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications.
    Calin GA; Croce CM
    J Clin Invest; 2007 Aug; 117(8):2059-66. PubMed ID: 17671640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An approach to forecast human cancer by profiling microRNA expressions from NGS data.
    Salim A; Amjesh R; Chandra SS
    BMC Cancer; 2017 Jan; 17(1):77. PubMed ID: 28122525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
    Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
    Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.
    Gaur A; Jewell DA; Liang Y; Ridzon D; Moore JH; Chen C; Ambros VR; Israel MA
    Cancer Res; 2007 Mar; 67(6):2456-68. PubMed ID: 17363563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for dietary regulation of microRNA expression in cancer cells.
    Davis CD; Ross SA
    Nutr Rev; 2008 Aug; 66(8):477-82. PubMed ID: 18667010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of micro-RNA profiling for cancer diagnosis.
    Cummins JM; Velculescu VE
    Oncogene; 2006 Oct; 25(46):6220-7. PubMed ID: 17028602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microRNA profile of prostate carcinoma obtained by deep sequencing.
    Szczyrba J; Löprich E; Wach S; Jung V; Unteregger G; Barth S; Grobholz R; Wieland W; Stöhr R; Hartmann A; Wullich B; Grässer F
    Mol Cancer Res; 2010 Apr; 8(4):529-38. PubMed ID: 20353999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and their role in gynecological tumors.
    Torres A; Torres K; Maciejewski R; Harvey WH
    Med Res Rev; 2011 Nov; 31(6):895-923. PubMed ID: 20358579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis.
    Chow TF; Youssef YM; Lianidou E; Romaschin AD; Honey RJ; Stewart R; Pace KT; Yousef GM
    Clin Biochem; 2010 Jan; 43(1-2):150-8. PubMed ID: 19646430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of personalized microRNA activity.
    Lee CC; Yen CJ; Liu T
    Gene; 2013 Apr; 518(1):101-6. PubMed ID: 23262342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of protein markers for serum diagnosis of cancer based on microRNA expression profiling].
    Bukurova IuA; Nikitina SL; Khankin SL; Krasnov GS; Lisitsin NA; Karpov VL; Beresten' SF
    Mol Biol (Mosk); 2011; 45(2):376-81. PubMed ID: 21634125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic regulation of microRNA expression in cancer.
    Choudhry H; Catto JW
    Methods Mol Biol; 2011; 676():165-84. PubMed ID: 20931397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
    Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
    Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-class cancer classification through gene expression profiles: microRNA versus mRNA.
    Peng S; Zeng X; Li X; Peng X; Chen L
    J Genet Genomics; 2009 Jul; 36(7):409-16. PubMed ID: 19631915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of expression profiling of circulating microRNAs in men with prostate cancer.
    Kelly BD; Miller N; Healy NA; Walsh K; Kerin MJ
    BJU Int; 2013 Jan; 111(1):17-21. PubMed ID: 22612403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs and future therapeutic applications in cancer.
    Casalini P; Iorio MV
    J BUON; 2009 Sep; 14 Suppl 1():S17-22. PubMed ID: 19785062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.